Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis

Fixed dynamometry is more sensitive than vital capacity or ALS rating scale

(2017) Patricia L. Andres et al.   MUSCLE & NERVE

Current view and perspectives in amyotrophic lateral sclerosis

(2017) Stéphane Mathis et al.   Neural Regeneration Research

The CREST-E study of creatine for Huntington disease

(2017) Steven M. Hersch et al.   NEUROLOGY

The Platform Trial

(2015) Scott M. Berry et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas

(2015) Yazmín Odia et al.   JOURNAL OF NEURO-ONCOLOGY

Venous thromboembolism in amyotrophic lateral sclerosis: A prospective study

(2014) M. Gladman et al.   NEUROLOGY

PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease

(2014) H. D. Rosas et al.   NEUROLOGY

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia

(2013) Christina Yap et al.   BMC Medical Research Methodology

Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

(2013) Mark E. Dudley et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysis of start-up, retention, and adherence in ALS clinical trials

(2013) N. Atassi et al.   NEUROLOGY

Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials

(2011) Patricia L. Andres et al.   MUSCLE & NERVE

How can we improve clinical trials in amyotrophic lateral sclerosis?

(2011) Paul H. Gordon et al.   Nature Reviews Neurology

Phase II Selection Design Trial of Concurrent Chemotherapy and Cetuximab Versus Chemotherapy Followed by Cetuximab in Advanced-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Study S0342

(2010) Roy S. Herbst et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

(2009) Petra Kaufmann et al.   ANNALS OF NEUROLOGY

A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS

(2008) Paul H. Gordon et al.   Amyotrophic Lateral Sclerosis

Design of phase II ALS clinical trials

(2008) David A. Schoenfeld et al.   Amyotrophic Lateral Sclerosis

Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS

(2008) Jeffrey Rosenfeld et al.   Amyotrophic Lateral Sclerosis

ALS drug development: Reflections from the past and a way forward

(2008) Swati Aggarwal et al.   Neurotherapeutics